VICTORIA SCHEIBEL: Open Payments
NPI 1871985804 · FLOURTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,649 in 95 payments from 18 companies in 2025. Trend: 2023 $3,021 · 2024 $2,967 · 2025 $1,649
Food & beverage: $1,649
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $514 |
| Janssen Biotech, Inc. | 13 | $288 |
| Ipsen Biopharmaceuticals, Inc | 4 | $101 |
| GENZYME CORPORATION | 5 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $84 |
| PFIZER INC. | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| Phathom Pharmaceuticals, Inc. | 5 | $62 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
| Aimmune Therapeutics, Inc. | 2 | $48 |
Products named: TREMFYA, RINVOQ, DUPIXENT, IQIRVO, XIFAXAN, CREON, LINZESS, SKYRIZI.
Industry payments across PA — which companies pay providers there.
